Kura Oncology (KURA) PT Raised to $40 at Brookline Capital Markets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts KURA Hot Sheet
Price: $7.61 --0%
Rating Summary:
18 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Rating Summary:
18 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Join SI Premium – FREE
Brookline Capital Markets analyst Leah Rush Cann raised the price target on Kura Oncology (NASDAQ: KURA) to $40.00 (from $35.00) while maintaining a Buy rating.
You May Also Be Interested In
- Modine Manufacturing (MOD) PT Lowered to $178 at Cantor Fitzgerald
- Hut 8 Mining Corp. (HUT) PT Lowered to $127 at Cantor Fitzgerald
- Datadog (DDOG) PT Lowered to $270 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
